Preventive effect of tranilast on oleic acid-induced lung injury in guinea pigs

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 9, 2004, Pages 1451-1454

  Ishitsuka, Yoichi ^a   Moriuchi, Hiroshi ^a   Yang, Changqing ^b   Kurita, Sumika ^a   Golbidi, Saeid ^c   Irikura, Mitsuru ^a   Irie, Tetsumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b YANBIAN UNIVERSITY   (China)

^c KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hypoxemia; Lung injury; Oleic acid; Pulmonary vascular hyper permeability; Tranilast

Indexed keywords

ANTIALLERGIC AGENT; OLEIC ACID; OXYGEN; TRANILAST; ANTHRANILIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL BLOOD; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GUINEA PIG; HYPOXEMIA; LUNG; LUNG INJURY; MALE; NONHUMAN; OXYGEN TENSION; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; BLOOD; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; PRESSURE; VASCULARIZATION;

ANIMALS; ANTHRANILIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAPILLARY PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; LUNG; MALE; OLEIC ACID; OXYGEN; PARTIAL PRESSURE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 16644387140     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1451     Document Type: Article

References (20)

1. Vincent J. L., Sakr Y., Ranieri V. M., Crit. Care Med., 31 (Suppl.), S296-S299 (2003).
2. Nuckton T. J., Alonso J. A., Kallet R. H., Daniel B. M., Pittet J.-F., Eisner M. D., Matthay M. A., N. Engl. J. Med., 346, 1281-1286 (2002).
3. Ware L. B., Matthay M. A., N. Engl. J. Med., 342, 1334-1349 (2000).
4. Capper E. A., Roshak A. K., Bolognese B. J., Podolin P. L., Smith T., Dewitt D. L., Anderson K. M., Marshall L. A., J. Pharmacol. Exp. Ther., 295, 1061-1069 (2000).
5. Suzawa H., Ichikawa K., Kikuchi S., Yamada K., Tsuchiya O., Hamano S., Komatsu H., Miyata H., Folia Pharmacol. Japon., 99, 241-246 (1992).
6. Nagai H., Tsuji F., Goto S., Koda A., Arch. Int. Pharmacodyn., 313, 161-175 (1991).
7. Schuster D. P., Am. J. Respir. Crit. Care Med., 149, 245-260 (1994).
8. Maclver R. W., Hustead R. F., Peltier L. F., J. Surg. Res., 23, 311-314 (1977).
9. Halilton R. W., Hustead R. F., Peltier L. F., Surgery St. Louis, 56, 53-56 (1964).
10. Clark D. A., Nieman G. F., Tompson A. M., J. Pediatr., 110, 765-770 (1987).
11. Moriuchi H., Arai I., Yuizono T., Intensive Care Med., 21, 1003-1008 (1995).
12. Isaji M., Miyata H., Ajisawa Y., Cardiovasc. Drug Rev., 16, 288-299 (1998).
13. Isaji M., Nakajoh M., Naito J., Biochem. Pharmacol., 36, 469-474 (1987).
14. Chikaraishi A., Hirahashi J., Takase O., Marumo T., Hishikawa K., Hayashi M., Saruta T., Eur. J. Pharmacol., 427, 151-158 (2001).
15. Koyama S., Takagi H., Otani A., Suzuma K., Nishimura K., Honda Y., Br. J. Pharmacol., 127, 537-545 (1999).
16. Moriuchi H., Yuizono T., Crit. Care Med., 23, 357-364 (1995).
17. Moriuchi H., Zaha M., Fukumoto T., Yuizono T., Intensive Care Med., 24, 709-715 (1998).
18. Yang C., Moriuchi H., Takase J., Ishitsuka Y., Irikura M., Irie T., Biol. Pharm. Bull., 26, 424-428 (2003).
19. Moriuchi H., Kashiwada Y., Arai I., Yuizono T., Pharmacol. Toxicol., 77, 238-240 (1995).
20. Mori H., Tanaka H., Kawada K., Nagai H., Koda A., Jpn. J. Pharmacol., 67, 279-289 (1995).